Comparison · NCT01694108-0f074784
BCG-vaccine vs Control Children: Atopic Dermatitis
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. BCG-vaccine vs Control Children: Atopic Dermatitis. Trial comparisons, record NCT01694108-0f074784. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01694108-0f074784
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.227 | 0.209 | 0.246 | wilson | |
| Risk in group 2 | 0.254 | 0.235 | 0.273 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0265 | -0.053 | -0.0000229 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.896 | 0.802 | 1 | log | |
| Odds ratio, group 1 over group 2 | 0.865 | 0.748 | 1 | log | |
| Number needed to treat, for one fewer participant with the outcome on BCG-vaccine than on Control Children | 37.7 | 18.9 | 43,700 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | BCG-vaccine | SS! strain 1331 standard dose | 466 | 2,052 | OG000 |
| Group 2 | Control Children | No intervention | 495 | 1,952 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Atopic Dermatitis
- Description
To test if BCG vaccination within 7 days after birth influence the risk of atopic dermatitis defined by clinical examination at 13 months of age using scoring atopic dermatitis (SCORAD) or by parental report of physician diagnosed atopic dermatitis in the telephone interview at 13 months of age.
- Time frame
- 13 months of age
- Population
This analysis includes children with follow-up data from clinical examination or telephone interview. As opposed to the register-based primary outcome, adherence to telephone-interview and clinical examination was slightly lower than 100%.
Source ClinicalTrials.gov
Trial
- Title
- Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.
- NCT number
- NCT01694108
- Phases
- PHASE4
- Conditions
- Prospective, Single-blind, Clinical, Trial, Intervention
- Interventions
- BCG-vaccine (SSI)
- Lead sponsor
- Lone Graff Stensballe
- Results first posted
- 2016-01-08
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01694108?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01694108-0f074784